The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...

The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.

Jefferies initiated coverage of ANI Pharmaceuticals (ANIP) with a Buy rating and $80 price target The firm expects continued momentum for the ...

The Rare Disease segment played a significant role in this growth, with Cortrophin Gel contributing $59.4 million, a 42.3% increase from the previous year. Additionally, the company has raised its ...

The Rare Disease segment played a significant role in this growth, with Cortrophin Gel contributing $59.4 million, a 42.3% increase from the previous year. Additionally, the company has raised its ...

ANI Pharmaceuticals (ANIP) stock was granted an Overweight rating by J.P. Morgan on Wednesday based on the company's growth ...

JPMorgan initiated coverage of ANI Pharmaceuticals (ANIP) with an Overweight rating and $85 price target ANI is a specialty pharmaceuticals ...

Nikhil Lalwani, President and CEO of ANI stated, "ILUVIEN's expanded label and the strengthening of our partnership with long ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME)ANI plans to begin marketing ILU ...

Uncertainties and risks include, but are not limited to: the ability of our approved products, including Cortrophin Gel, ILUVIEN and YUTIQ, to achieve commercialization at levels of market ...